{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T08:23:04Z","timestamp":1789806184247,"version":"4.0.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN 2015\\u201306455"],"award-info":[{"award-number":["RGPIN 2015\\u201306455"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["2024\\u201306455"],"award-info":[{"award-number":["2024\\u201306455"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008644","name":"Faculty of Medicine, McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008644","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003151","name":"Nature et technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012679","name":"Institut de Cardiologie de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017658","name":"Canadian Open Neuroscience Platform","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017658","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013739","name":"Pfizer Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neurobiolaging.2025.04.011","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:26:47Z","timestamp":1746124007000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer's disease"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7451-5010","authenticated-orcid":false,"given":"Safa","family":"Sanami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Intzandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Huck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Iturria-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5137-5019","authenticated-orcid":false,"given":"Claudine J.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Prevent-AD research group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbi.2021.01.010","article-title":"Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults","volume":"94","author":"Albrecht","year":"2021","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2021.01.010","article-title":"Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults","author":"Albrecht","year":"2021","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/mrm.25197","article-title":"Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia","volume":"73","author":"Alsop","year":"2015","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awv278","article-title":"Regional brain hypometabolism is unrelated to regional amyloid plaque burden","author":"Altmann","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib5","doi-asserted-by":"crossref","unstructured":"Amiri, F., Safiri, S., Shamekh, A., Ebrahimi, A., Sullman, M.J.M., 2025. Prevalence, Deaths and Disability- Adjusted Life Years Due to Alzheimer \u2019 s disease and other dementias in Middle East and North Africa, 1990 \u2013 2021 1\u201313.","DOI":"10.1038\/s41598-025-89899-w"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib6","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/S0140-6736(17)32399-1","article-title":"Why do so many clinical trials of therapies for Alzheimer\u2019s disease fail?","volume":"390","author":"Anderson","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/cvr\/cvp241","article-title":"Interleukin 8 and cardiovascular disease","volume":"84","author":"Apostolakis","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib8","article-title":"Single SPECT measures of cerebral cortical perfusion reflect time-index estimation of dementia severity in Alzheimer\u2019s disease","author":"Ashford","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/mrm.21670","article-title":"Regression algorithm correcting for partial volume effects in arterial spin labeling MRI","author":"Asllani","year":"2008","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib10","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","article-title":"A reproducible evaluation of ANTs similarity metric performance in brain image registration","volume":"54","author":"Avants","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib11","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1402-13.2013","article-title":"Changes in brain function occur years before the onset of cognitive impairment","author":"Beason-Held","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-023-04616-z","article-title":"Association between increased serum interleukin-8 levels and improved cognition in major depressive patients with SSRIs","volume":"23","author":"Cai","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-012-8251-3","article-title":"A\u03b2 toxicity in Alzheimer\u2019s disease","author":"Cavallucci","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/WAD.0b013e3181b4f736","article-title":"ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia","author":"Chao","year":"2010","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2007.01.070","article-title":"A\u03b2 peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons","author":"Clifford","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.47","article-title":"Longitudinal brain activity changes in asymptomatic Alzheimer disease","author":"Codispoti","year":"2012","journal-title":"Brain Behav."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000010256","article-title":"Multitracer model for staging cortical amyloid deposition using PET imaging","author":"Collij","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.gheart.2013.01.001","article-title":"Cardiovascular disease risk assessment: insights from Framingham","author":"D\u2019Agostino","year":"2013","journal-title":"Glob. Heart"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gheart.2013.01.001","article-title":"Cardiovascular disease risk assessment: insights from Framingham","volume":"8","author":"D\u2019Agostino","year":"2013","journal-title":"Glob. Heart"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib22","first-page":"1","article-title":"Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment","volume":"15","author":"Dang","year":"2023","journal-title":"Alzheimer\u2019s. Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2020.05.008","article-title":"Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer\u2019s disease","author":"Dicks","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X211020863","article-title":"Evidence of cerebral hemodynamic dysregulation in middle-aged APOE \u03b54 carriers: the PREVENT-dementia study","author":"Dounavi","year":"2021","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X231173587","article-title":"Differential association of cerebral blood flow and anisocytosis in APOE \u03b54 carriers at midlife","author":"Dounavi","year":"2023","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib26","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-200034","article-title":"Cerebral blood flow is associated with diagnostic class and cognitive decline in alzheimer\u2019s disease","author":"Duan","year":"2020","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib27","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-210199","article-title":"Cerebral blood flow predicts conversion of mild cognitive impairment into alzheimer\u2019s disease and cognitive decline: an arterial spin labeling follow-up study","author":"Duan","year":"2021","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3233\/JAD-230772","article-title":"A scoping review of alzheimers disease hypotheses: an array of uni- and multi-factorial theories","volume":"99","author":"Duchesne","year":"2024","journal-title":"J. Alzheimer\u2019s. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-022-05958-8","article-title":"Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals","author":"Ebenau","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s00429-010-0283-8","article-title":"Atrophy in the parahippocampal gyrus as an early biomarker of alzheimer\u2019s disease","author":"Ech\u00e1varri","year":"2011","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2022.12.003","article-title":"Vascular contributions to Alzheimer\u2019s disease","author":"Eisenmenger","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-34068-0","article-title":"Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study","volume":"13","author":"Etter","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.26810","article-title":"Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer\u2019s disease","author":"Fazlollahi","year":"2020","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13061","article-title":"Pathological changes within the cerebral vasculature in Alzheimer\u2019s disease: new perspectives","author":"Fisher","year":"2022","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/ana.24186","article-title":"Cerebrospinal fluid \u03b2-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease","author":"Fortea","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-015-0261-z","article-title":"The utility of cerebral blood flow as a biomarker of preclinical alzheimer\u2019s disease","author":"Hays","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-015-0261-z","article-title":"The utility of cerebral blood flow as a biomarker of preclinical Alzheimer\u2019s disease","author":"Hays","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-023-00976-6","article-title":"Clinical trials of new drugs for Alzheimer disease: a 2020\u20132023 update","volume":"30","author":"Huang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X19862873","article-title":"Higher cardiovascular fitness level is associated with lower cerebrovascular reactivity and perfusion in healthy older adults","author":"Intzandt","year":"2020","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s. Dement"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib43","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/mrm.29272","article-title":"Cerebral oxygen extraction fraction MRI: techniques and applications","volume":"88","author":"Jiang","year":"2022","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib44","doi-asserted-by":"crossref","DOI":"10.3988\/jcn.2022.0088","article-title":"Hypoperfusion precedes tau deposition in the entorhinal cortex: a retrospective evaluation of ADNI-2 data","author":"Kapadia","year":"2023","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib45","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"80","author":"Koch","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s10548-018-0675-2","article-title":"Patterns of grey matter atrophy at different stages of parkinson\u2019s and Alzheimer\u2019s Diseases and relation to cognition","author":"Kunst","year":"2019","journal-title":"Brain Topogr."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib47","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1002\/mrm.26325","article-title":"Fast measurement of blood T1 in the human carotid artery at 3T: accuracy, precision, and reproducibility","volume":"77","author":"Li","year":"2017","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/CIA.S357558","article-title":"Neuroinflammation as a potential therapeutic target in Alzheimer\u2019s disease","volume":"17","author":"Liu","year":"2022","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2022.12.006","article-title":"Capillary dysfunction correlates with cortical amyloid load in early Alzheimer\u2019s disease","volume":"123","author":"Madsen","year":"2023","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2019.2214","article-title":"Staging \u03b2 -amyloid pathology with amyloid positron emission tomography","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awu043","article-title":"Association of brain amyloid-(beta) with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment","author":"Mattsson","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib52","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awu043","article-title":"Association of brain amyloid-\u03b2 with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment","author":"Mattsson","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib53","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/jnnp-2020-322924","article-title":"Regional hyperperfusion in cognitively normal APOE \u03f54 allele carriers in mid-life: analysis of ASL pilot data from the PREVENT-dementia cohort","volume":"91","author":"McKiernan","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/genes13050837","article-title":"Feature fusion and detection in Alzheimer\u2019s disease using a novel genetic multi-kernel SVM based on MRI imaging and gene data","volume":"13","author":"Meng","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib55","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007232","article-title":"Intrepad","volume":"92","author":"Meyer","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib56","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1177\/0271678X16683690","article-title":"The spatial coefficient of variation in arterial spin labeling cerebral blood flow images","volume":"37","author":"Mutsaerts","year":"2017","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/hbm.22173","article-title":"Covarying alterations in A\u03b2 deposition, glucose metabolism, and gray matter volume in cognitively normal elderly","author":"Oh","year":"2014","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib58","doi-asserted-by":"crossref","DOI":"10.1177\/0271678X231178993","article-title":"Genetic, vascular and amyloid components of cerebral blood flow in a preclinical population","author":"Padrela","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib59","article-title":"The effect of chronic cerebral hypoperfusion on the pathology of Alzheimer\u2019s disease: a positron emission tomography study in rats","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz091","article-title":"Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer\u2019s disease","author":"Phillips","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib61","first-page":"1","article-title":"Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimers disease mice","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2016.00321","article-title":"Cerebral blood flow and A\u03b2-amyloid estimates by WARM analysis of [11C]PiB uptake distinguish among and between neurodegenerative disorders and aging","author":"Rodell","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2021.02.003","article-title":"Lower cerebral perfusion is associated with tau-PET in the entorhinal cortex across the Alzheimer\u2019s continuum","author":"Rubinski","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/ana.20493","article-title":"Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study","author":"Ruitenberg","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib65","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/brain\/aww193","article-title":"Amyloid-\u03b2 deposition and regional grey matter atrophy rates in dementia with Lewy bodies","volume":"139","author":"Sarro","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib66","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.neuroimage.2007.09.031","article-title":"Construction of a 3D probabilistic atlas of human cortical structures","volume":"39","author":"Shattuck","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib67","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer Disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"Jama"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.643468","article-title":"Cerebrovascular reactivity measurement using magnetic resonance imaging: a systematic review","volume":"12","author":"Sleight","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib69","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.108.051946","article-title":"Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?","author":"Sojkova","year":"2008","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib70","doi-asserted-by":"crossref","DOI":"10.1159\/000338185","article-title":"CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly","author":"Stomrud","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain - implications for Alzheimer disease","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib72","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-017-0299-x","article-title":"Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment","author":"Ten Kate","year":"2017","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib73","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neurobiolaging.2015.10.015","article-title":"Gray matter network disruptions and amyloid beta in cognitively normal adults","volume":"37","author":"Tijms","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102733","article-title":"Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer\u2019s disease","author":"Tremblay-Mercier","year":"2021","journal-title":"NeuroImage Clin."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.04.011_bib75","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2174\/1381612826666201118092422","article-title":"Anti-Neuroinflammatory potential of polyphenols by inhibiting NF-\u03baB to halt Alzheimer\u2019s Disease","volume":"27","author":"Uddin","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib76","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-020-04831-w","article-title":"Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer\u2019s disease","author":"Visser","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12364","article-title":"Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults","author":"Vogt","year":"2022","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib78","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/alz.12666","article-title":"Longitudinal changes in cerebral blood flow and their relation with cognitive decline in patients with dementia: current knowledge and future directions","volume":"19","author":"Weijs","year":"2023","journal-title":"Alzheimer\u2019s. Dement."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib79","doi-asserted-by":"crossref","DOI":"10.1212\/01.wnl.0000324924.91351.7d","article-title":"MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study","author":"Whitwell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.10.023","article-title":"Regional patterns of gray matter volume, hypometabolism, and beta-amyloid in groups at risk of Alzheimer\u2019s disease","author":"Wirth","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2011.02.080","article-title":"Pseudocontinuous arterial spin labeling perfusion magnetic resonance imaging-a normative study of reproducibility in the human brain","author":"Wu","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2014-309105","article-title":"Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer\u2019s disease","author":"Yi","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib83","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7040097","article-title":"Reasons for failed trials of disease-modifying treatments for alzheimer disease and their contribution in recent research","author":"Yiannopoulou","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2021.755152","article-title":"Sex differences in cerebral blood flow and serum inflammatory cytokines and their Relationships in mild traumatic brain injury","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2006.10.014","article-title":"Alzheimer disease, the two-hit hypothesis: an update","author":"Zhu","year":"2007","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.neurobiolaging.2025.04.011_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:06:18Z","timestamp":1778565978000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458025000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":86,"alternative-id":["S0197458025000867"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.04.011","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal relationships among cerebrospinal fluid biomarkers, cerebral blood flow, and grey matter volume in individuals with a familial history of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}